Tech Company Financing Transactions

Renovacor Funding Round

BioAdvance Ventures, Broadview Ventures and Novartis Venture Fund participated in a $11 million Series A funding round for Renovacor. The funding round was announced on 8/16/2019.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
New York, NY 10001
USA

Phone

Undisclosed

Website

www.renovacorinc.com

Email Address

[email protected]

Overview

Renovacor, headquartered in Philadelphia, is a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-based treatments for cardiovascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Magdalene Cook

        

Browse more venture capital transactions:

Prev: 8/16/2019: Equiem venture capital transaction
Next: 8/16/2019: Mason venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary